December 13, 2021 - Today was the final day of ASH but it was still full of information, and to be honest, I’m a bit brain-fried. The day began with the IMWG Conference series (with the...
Diagnosed with myeloma in 1995, Jack is strong proponent of patients participating in clinical trials so that, in the future, myeloma and other cancers will be known as curable diseases. He is a proud facilitator of the San Francisco Bay Area Myeloma Support Group.
Follow Jack on Twitter: @JackMAiello
Support Group Website: Multiple Myeloma Support for the SF Bay Area (sfbayareamyelomasupport.org)
ASH Day 2: Which CAR to Hitch a Ride with?
December 12, 2021 - Today began with watching a few presentations that focused on the epidemiology of myeloma patients. For example, abstract 400 examined COVID-19 vaccine effectiveness for multiple...
ASH 2021 Day 1: From Iceland to Bispecifics
Dec 11, 2021 - The day began at 3:30 a.m. PST for the privilege of being able to attend the International Myeloma Working Group (IMWG) meeting. The IMWG has over 250 myeloma specialists who meet...
Symposium Day: Insightful Comments from Myeloma Specialists
The Friday before the official start of ASH is always considered as Symposium Day. Symposiums typically last a couple of hours and involve several myeloma expert doctors discussing patient cases and...
Pre-ASH Blog: Hybrid Meeting (Virtual for Me), Exciting Updates
There is no other single conference where so much information is presented about myeloma. Information about so many topics is provided: how to treat MM patients in various stages; results of phase...